skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
We are delighted to announce the finalists for the 2018 Clinical and Research Excellence Awards:

Best in Health Economics and Outcomes Research

Bracket, Pfizer & ICON, Study of BYOD ePRO Equivalence Across Different Device Types

EMD Serono, Global Evidence & Value Development MAVENCLAD

Merck KGaA, Darmstadt, Germany, Merkel Cell Carcinoma (MCC) Observational Study for Historic Comparison

 

Best Patient-Focused Technological Development

Bracket, Bracket Mobile ePRO

CRF Health, TrialConsent eCOA and eConsent hybrid technology

Data MATRIX, MATRIX ePRO

ePatientFinder    

ERT, Voice Assistant Data Capture

HealthiVibe, HealthiPerspectives

 

Best Sponsor-Focused Technological Development

Bioclinica, SMART Submit

CluePoints, RBM and CSM – Miracle Pills for the Clinical R&D Industry

ERT, Centralized Clinical Trial Analytics Solution

goBalto, Activate Configuration Designer

ICON, FIRECREST Pre-Screen 

Medidata Solutions, Medidata Strategic Monitoring

Oracle, Oracle Health Sciences Clinical One Platform


Medidata Clinical Partnership of the Year
Sponsored by Medidata Solutions

Cytel and Biogen

Inovio, GBM-001 Team: Inovio and Regeneron

Merck KGaA, Darmstadt, Germany and Avillion       

Myovant Sciences and Takeda Pharmaceuticals          

Novartis and Amgen           

Novartis and University of Pennsylvania

Theravance Biopharma and Mylan  

 

Clinical Research Team of the Year
Sponsored by Oracle Health Sciences

AMAG & ICON Adult Iron Deficiency Trial

Celgene & ICON CAR T Core Team

Otsuka Digital Medicine Team

Paratek Pharmaceuticals, Omadacycline Clinical Development Team

 

Clinical Trial Result of the Year
Sponsored by Cytel

Ardelyx, T3MPO-2 Phase 3 Study

Boehringer Ingelheim, EMPA-REG OUTCOME trial

Eli Lilly and Company, Three Phase 3 Studies of Galcanezumab for the Prevention of Episodic and Chronic Migraine

F. Hoffmann-La Roche, ALEX clinical trial

Novartis, KYMRIAH™ (tisagenlecleucel) suspension for intravenous infusion

Paratek Pharmaceuticals, Phase 3 Clinical Trial Results for a Novel Antibiotic

 

Excellence in Rare Disease Drug Development

Alnylam Pharmaceuticals, Hereditary ATTR (hATTR) amyloidosis

Atlantic Healthcare, Alicaforsen – accelerated recruitment to a pivotal Phase 3 study in IBD pouchitis

Deciphera Pharmaceuticals, DCC-2618 for Gastrointestinal Stromal Tumors (GIST)

Global Blood Therapeutics (GBT), voxelotor (GBT440)

Otsuka Pharmaceutical Development & Commercialization, Autosomal Dominant Polycystic Kidney Disease (ADPKD) Tolvaptan Team

Rhythm Pharmaceuticals, Setmelanotide for Rare Genetic Disorders of Obesity

 

Most Innovative Clinical Trial Design
Sponsored by Syneos Health

Almac Clinical Technologies

Forty Seven          

Global Blood Therapeutics (GBT), voxelotor (GBT440)

Nestlé Health Science in collaboration with Cytel, Dysphagia Detection System (DDS) Device

Otsuka Pharmaceutical Development & Commercialization, Autosomal Dominant Polycystic Kidney Disease (ADPKD) Tolvaptan Team

 

Most Successful Early Phase Research (Preclinical & Phase I)

Altasciences Clinical Research, Full-service innovative cannabis research solutions

AveXis, Phase 1 Clinical Trial of AVXS-101 Gene Replacement Therapy for Spinal Muscular Atrophy Type 1

Catalyst Biosciences, Achievement of Stable Normal Factor IX Blood Levels in a Preclinical Subcutaneous Dosing Model

Forty Seven          

Viking Therapeutics, VK2809 for Glycogen Storage Disease Ia

 

Marquee Award for R&D Excellence

AstraZeneca

BioMarin Pharmaceuticals

Merck & Co.

Novartis

Pfizer

Roche

Vertex Pharmaceuticals

 

 

Trophies are designed and manufactured by

gaudio_logo

 

 

Keep up to date